Study summary

Purpose of the study was to assess the effect of enzalutamide on time to Prostate Specific Antigen (PSA) progression as compared to placebo in chemotherapy naïve participants with progressive metastatic prostate cancer who have failed androgen deprivation therapy.

Additional Study Details

Phase
Phase 3
Product
  • Enzalutamide
  • Placebo
  • Type
    Interventional
    Masking
    Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
    Enrollment number
    395
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for An Asian study to evaluate efficacy and safety of oral enzalutamide in progressive metastatic prostate cancer participants? Contact us by filling out your information to the right and we’ll respond to you.

    • A caregiver
    • A healthcare provider
    • A parent
    • A patient
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      TW00303
      Taichung, Taiwan, Province of China
      Completed
      CN00109
      Wu Han, China
      Completed
      CN00112
      Beijing, China
      Withdrawn
      CN00120
      Nanjing, China
      Completed
      TW00309
      Kaohsiung, Taiwan, Province of China
      Completed
      KR00209
      Seoul, Republic of Korea
      Completed
      KR00202
      Seongnam-si, Republic of Korea
      Completed
      CN00113
      Shanghai, China
      Completed
      KR00204
      Seoul, Republic of Korea
      Completed
      CN00105
      Shanghai, China
      Completed
      CN00103
      Beijing, China
      Completed
      TW00305
      Taoyuan County, Taiwan, Province of China
      Completed
      CN00104
      Beijing, China
      Completed
      CN00119
      Soochow, China
      Completed
      CN00118
      Wenzhou, China
      Completed
      CN00106
      Beijing, China
      Completed
      TW00304
      Taipei, Taiwan, Province of China
      Completed
      CN00126
      Shanghai, China
      Completed
      KR00207
      Busan, Republic of Korea
      Completed
      CN00127
      Beijing, China
      Completed
      HK00402
      Hong Kong, Hong Kong
      Completed
      KR00214
      Anyang, Republic of Korea
      Completed
      KR00206
      Seoul, Republic of Korea
      Completed
      TW00302
      Taichung, Taiwan, Province of China
      Completed
      TW00301
      Taipei, Taiwan, Province of China
      Completed
      KR00201
      Incheon, Republic of Korea
      Completed
      CN00124
      Xi'an, China
      Completed
      KR00210
      Seoul, Republic of Korea
      Completed
      KR00215
      Seoul, Republic of Korea
      Completed
      KR00203
      Daegu, Republic of Korea
      Completed
      CN00125
      Tianjin, China
      Completed
      CN00111
      Beijing, China
      Completed
      CN00114
      Beijing, China
      Completed
      CN00115
      Beijing, China
      Completed
      KR00212
      Cheongju, Republic of Korea
      Completed
      KR00213
      Daejeon, Republic of Korea
      Completed
      TW00308
      Tainan, Taiwan, Province of China
      Completed
      TW00306
      Taipei, Taiwan, Province of China
      Completed
      CN00121
      Changsha, China
      Completed
      CN00110
      Nanjing, China
      Completed
      CN00108
      Shanghai, China
      Completed
      KR00211
      Seoul, Republic of Korea
      Completed
      CN00107
      Hangzhou, China
      Completed
      KR00208
      Seoul, Republic of Korea
      Completed
      KR00205
      Busan, Republic of Korea
      Completed
      TW00307
      Tainan, Taiwan, Province of China
      Completed
      CN00102
      Shanghai, China
      Completed
      CN00117
      Nanjing, China

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?